채용
Bluebird Bio
Bluebird Bio
Develops gene therapies for severe genetic disorders.
Gene Therapy
Biotechnology
Clinical Research
Genetic Engineering
Cell Biology
채용 중인 포지션
0개 포지션
현재 채용 중인 포지션이 없습니다
제품 및 서비스
ZY
Zynteglo
Gene Therapy
Zynteglo
Gene Therapy
Skysona
Gene Therapy
SK
Skysona
Gene Therapy
LE
LentiGlobin
Gene Therapy
LE
Lenti-D
Gene Therapy
Lenti-D
Gene Therapy Research
BB
bb1111
Cell Therapy
bb2121 (ide-cel)
CAR-T Cell Therapy
bb21217
CAR-T Cell Therapy
Gene Therapy Manufacturing Services
Manufacturing Services
BB
bb21217
Cell Therapy
유사 기업
Editas Medicine
Public
Genome editing company
Cambridge, Massachusetts, United States
201-500
Valuation $1.2B
Eli Lilly
Public
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
10,001+
Valuation $588B
727 open jobs
Boston Scientific
Public
Leading company in the technology industry
Marlborough, Massachusetts
10,001+
Valuation $58B
190 open jobs
Invitae
Public
Biotechnology company.
San Francisco, CA
501-1,000
Gilead Sciences
Public
Biopharmaceutical company
Foster City, California, United States
10,001+
Valuation $85B
171 open jobs
Vir Biotechnology
Public
Immunology-focused biotech
San Francisco, California, United States
201-500
Valuation $1.2B
4 open jobs
뉴스 & 버즈
All
X
News
HN
YouTube
Bluebird Bio net income 2016-2019 - Statista
Statista
News
·
1개월 전
bluebird bio sees higher offer for company from Ayrmid Pharma - MSN
Source: MSN
google-news
·
2개월 전
Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model - Pharmaceutical Executive
Pharmaceutical Executive
News
·
3개월 전
PepGen Inc.
PepGen Inc. appoints Joseph Vittiglio as Chief Business and Legal Officer, bringing over 20 years of experience in the biotechnology sector. He previously worked at bluebird bio and Finch Therapeutics and will help advance PepGen's PGN-EDODM1 program. *PepGen Inc. [PEPG](https://www.google.com/finance/quote/PEPG:NASDAQ) is headquartered in Boston, MA.* [Source](https://www.sec.gov/Archives/edgar/data/1835597/000119312525310544/pepg-ex99_1.htm)
·
4개월 전
·
1
Beam Therapeutics ($BEAM) Valuation Model: Why Fair Value is $125 Based on 2025 Liquidity & ASH Data
(Disclaimer: I am long $BEAM. This is not financial advice. I have had my valuation models cited by financial news algorithms before, but do your own research.) The Executive Summary (TL;DR) We are currently witnessing a mathematical dislocation in Beam Therapeutics ($BEAM). • The Trap: Official Short Interest (20.55M shares) now exceeds the estimated "Tradable Float" (~14M shares). • The Catalyst: ASH 2025 Data (Saturday) confirms "Best-in-Class" safety & efficacy, while competitors ($N
·
4개월 전
·
7
·
5
더 보기 (15개 남음)
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
리뷰
3.8
10개 리뷰
워라밸
3.2
보상
3.5
문화
4.1
커리어
2.8
경영진
2.3
68%
친구에게 추천
장점
Supportive team and colleagues
Great team culture and collaboration
Good benefits and compensation
단점
Poor management and lack of direction
Limited career advancement opportunities
High pressure and demanding workload
연봉 정보
56개 데이터
Director
Junior/L3
Mid/L4
Senior/L5
Director
3개 리포트
$246,359
총 연봉
기본급
$214,225
주식
-
$246,359
$246,359
면접 경험
2개 면접
난이도
3.0
/ 5
소요 기간
2-5w
합격률
50%
경험
긍정 50%
보통 50%
부정 0%
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Offer
연락처 및 위치